Encore Dermatology Revenue and Competitors
Estimated Revenue & Valuation
- Encore Dermatology's estimated annual revenue is currently $502.5k per year.
- Encore Dermatology's estimated revenue per employee is $100,500
- Encore Dermatology's total funding is $76.7M.
Employee Data
- Encore Dermatology has 5 Employees.
- Encore Dermatology grew their employee count by -17% last year.
Encore Dermatology's People
| Name | Title | Email/Phone |
|---|
Encore Dermatology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $53.7M | 267 | 16% | N/A | N/A |
#2 | $53.1M | 264 | 21% | N/A | N/A |
#3 | $69.1M | 344 | 26% | N/A | N/A |
#4 | $22.1M | 110 | -10% | N/A | N/A |
#5 | $151.8M | 755 | 11% | N/A | N/A |
#6 | $63.9M | 318 | 13% | N/A | N/A |
#7 | $29.9M | 149 | 13% | N/A | N/A |
#8 | $1.7M | 17 | -6% | $114.3M | N/A |
#9 | $6.8M | 34 | -6% | N/A | N/A |
#10 | $12.5M | 62 | -9% | N/A | N/A |
What Is Encore Dermatology?
Headquartered in Malvern, Pennsylvania, Encore Dermatology is a privately held fully integrated dermatology company with a mission committed to delivering innovative prescription therapies and medical devices to dermatologists focusing on customer service and improving the quality-of-life of patients. Encore has a wide range of medical dermatology products, treating a number of topical disease states such as acne and atopic dermatitis. Encore Dermatology is rapidly expanding through acquisitions, in- licensing and co-marketing opportunities.
keywords:N/A
$76.7M
Total Funding
5
Number of Employees
$502.5k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Encore Dermatology News
... Bayer HealthCare, Encore Dermatology Inc., Meda Pharmaceuticals, Allergan Plc. (Republic of Ireland) and Bristol-Myers Squibb.
... Factors and How Companies are Responding Accordingly | Sanofi S.A., Encore Dermatology Inc, AbbieVie Inc., F. Hoffmann-La Roche AG,.
... AbbVie Inc., Encore Dermatology, Inc., Astellas Pharma Inc., Mylan N.V., AstraZeneca, 3M, and Teva Pharmaceutical Industries Ltd.
Encore Dermatology, Inc., a Malvern, Pennsylvania-based dermatologically-focused specialty pharmaceutical company, received a $20m venture loan facility from Horizon Technology Finance Corporation (NASDAQ: HRZN). $15m out of the total financing has been initially funded. The capital will enabl ...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.1M | 5 | -29% | $36M |
#2 | $0.6M | 5 | -29% | N/A |
#3 | $0.1M | 5 | -29% | $12M |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.5M | 5 | -17% | N/A |